Engineering Gut Microbiome to Target Breast Cancer
Condition(s):Breast CancerLast Updated:May 21, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:May 21, 2020Completed
Condition(s):Irritable Bowel SyndromeLast Updated:July 11, 2012Unknown status
Condition(s):Irritable Bowel Syndrome With ConstipationLast Updated:December 26, 2023Completed
Condition(s):Cancer – Solid TumoursLast Updated:March 12, 2021Terminated
Condition(s):Insulin SensitivityLast Updated:October 15, 2021Completed
Condition(s):Colorectal Cancer; Surgery; LAP; Anastomotic Leak; Microbial SubstitutionLast Updated:April 18, 2023Completed
Condition(s):ProbioticsLast Updated:November 6, 2017Completed
Condition(s):MicrobiotaLast Updated:February 5, 2024Completed
Condition(s):Respiratory Tract InfectionsLast Updated:July 10, 2019Completed
Condition(s):Type1diabetes; Type1 Diabetes MellitusLast Updated:November 30, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.